Vimarsana
Biggest News Aggregation in the World

Page 2 - World Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from World Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In World Study Today - Breaking & Trending Today

Regeneron to Highlight Scientific Advancements Across Diversified Pipeline in Difficult-to-Treat Blood Cancers and Disorders at ASH - Vimarsana News

Regeneron to Highlight Scientific Advancements Across Diversified Pipeline in Difficult-to-Treat Blood Cancers and Disorders at ASH

Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse large B-cell lymphoma Additional presentations...

Mirati announces Adagrasib (KRAZATI™) Receives Breakthrough Therapy Designation from FDA for Patients with Advanced, KRAS-Mutated Colorectal Cancer and NEJM Publishes Phase 1b/2 Data from Adagrasib With or Without Cetuximab in Colorectal Cancer - Vimarsana News

Mirati announces Adagrasib (KRAZATI™) Receives Breakthrough Therapy Designation from FDA for Patients with Advanced, KRAS-Mutated Colorectal Cancer and NEJM Publishes Phase 1b/2 Data from Adagrasib With or Without Cetuximab in Colorectal Cancer

U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for adagrasib in combination with cetuximab in patients with KRASG12C-mutated advanced colorectal cancer whose... | December 21, 2022

Neurocrine Biosciences Presents Real-World Parkinson's Disease Patient Characteristics From ONGENTYS® (opicapone) Open-Label Study at ANA2022 - Vimarsana News

Neurocrine Biosciences Presents Real-World Parkinson's Disease Patient Characteristics From ONGENTYS® (opicapone) Open-Label Study at ANA2022

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented data detailing the baseline characteristics of patients with Parkinson's disease...

Comorbidities Key to Serious Infections With IBD Treatment - Vimarsana News

Comorbidities Key to Serious Infections With IBD Treatment

Older IBD patients with comorbidities are less likely to be hospitalized due to an infection if they are treated with vedolizumab or ustekinumab than with an anti-TNF agent, suggests a US study.

Stillbirths & deaths of newborns have hit "critical levels" and cases of ovarian cancer are at an all time high - Are the Covid-19 vaccines to blame? -- Health & Wellness -- Sott.net - Vimarsana News

Stillbirths & deaths of newborns have hit "critical levels" and cases of ovarian cancer are at an all time high - Are the Covid-19 vaccines to blame? -- Health & Wellness -- Sott.net

Data available from Public Health Scotland shows that cases of ovarian cancer in 2021 are much higher than the 2017-2019 average, and deaths of new-born babies have reached the upper warning threshold indicating factors beyond random variation...

Source: sott.net